The Asia Pacific oligonucleotide synthesis market is expected to reach US$ 872.98 Mn in 2027 from US$ 334.26 Mn in 2018 the market is estimated to grow with a CAGR of 14.7% from 2019-2027.
The growth of the Oligonucleotide Synthesis market is driven by the factors such as, the growing use of synthesized oligonucleotides and government support for biotechnology research in Asia Pacific. However, the market is likely to slower down its growth due to dearth of skilled professional in the region.
The high growth of the market is anticipated on account of the rise in the investment are enabling technological developments and standard biological parts. For Instance, The Biotechnology Industry Research Assistance Council (BIRAC) is a public entity developed by the DBT, government of India, which aims to strengthen and empower the emerging biotech enterprises. DBT along with the BIRAC plays important role in transforming the biotech sector by Make in India and Startup India and the aim is to inform the India Bioeconomy to US$ 100 billion by the 2025. Developments such as partnerships and increasing focus on synthetic biology research is expected to contribute to the growth of the market.
Japan is expected to lead the market in the Asia Pacific region owing to the rising prevalence of chronic diseases such as coronary diseases & cancer and increase in awareness regarding cancer in the country. Moreover the government initiative for research activities, collaboration among major player in country. Therefore, considering the above mentioned factors the growth of the market in the country is likely to contribute largest share in the Asia Pacific region during the forecast period.
Exhibit: Rest of Asia Pacific Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)
ASIA PACIFIC OLIGONUCLEOTIDE SYNTHESIS – MARKET SEGMENTATION
By Product
By Application
By End User
By Geography
Company Profiles
| Report Attribute | Details |
|---|---|
| Market size in 2018 | US$ 334.26 Million |
| Market Size by 2027 | US$ 872.98 Million |
| CAGR (2019 - 2027) | 14.7% |
| Historical Data | 2016-2017 |
| Forecast period | 2019-2027 |
| Segments Covered |
By Product
|
| Regions and Countries Covered |
Asia-Pacific
|
| Market leaders and key company profiles |
|
The Asia Pacific Oligonucleotide Synthesis Market is valued at US$ 334.26 Million in 2018, it is projected to reach US$ 872.98 Million by 2027.
As per our report Asia Pacific Oligonucleotide Synthesis Market, the market size is valued at US$ 334.26 Million in 2018, projecting it to reach US$ 872.98 Million by 2027. This translates to a CAGR of approximately 14.7% during the forecast period.
The Asia Pacific Oligonucleotide Synthesis Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific Oligonucleotide Synthesis Market report:
The Asia Pacific Oligonucleotide Synthesis Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Asia Pacific Oligonucleotide Synthesis Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Asia Pacific Oligonucleotide Synthesis Market value chain can benefit from the information contained in a comprehensive market report.
Please tell us your area of interest
(Market Segments/ Regions and Countries/ Companies)
E 1803, Panchshil Towers,
Wagholi, Haveli,
Pune - 412207,
Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Asia Pacific Oligonucleotide Synthesis Market
